Concepedia

Shingo Kato

SK

Statistics

Publications

32

Citations

1.6K

H-Index

21

Active since

1999

Affiliations

Saitama Medical University(Current)

Social Insurance Saitama Chuo Hospital

Toho University

Toho University Medical Center Sakura Hospital

Tokyo Medical and Dental University

Shingo Kato is an author at Saitama Medical University specializing in inflammatory bowel disease, medicine, and gastrointestinal inflammation.

ORCID

Publications per year

1999–2023

32

Publications

32

Adalimumab Monotherapy and a Combination with Azathioprine for Crohn’s Disease: A Prospective, Randomized Trial

Takayuki Matsumoto, Satoshi Motoya, Kenji Watanabe et al. · Journal of Crohn s and Colitis · 2016 · 239 citations · Full text

, , +14

Amelioration of Murine Experimental Colitis by Inhibition of Mucosal Addressin Cell Adhesion Molecule-1

Shingo Kato, Ryota Hokari, Koji Matsuzaki et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 137 citations

, , +17

Efficacy of Endoscopic Balloon Dilation for Small Bowel Strictures in Patients With Crohn’s Disease: A Nationwide, Multi-centre, Open-label, Prospective Cohort Study

Fumihito Hirai, Akira Andoh, Fumiaki Ueno et al. · Journal of Crohn s and Colitis · 2017 · 94 citations

, , +14

TNF-alpha Activates MUC2 Transcription via NF-kappaB but Inhibits via JNK Activation

Dae Ho Ahn, Suzanne Crawley, Ryota Hokari et al. · Cellular Physiology and Biochemistry · 2005 · 83 citations · Full text

, , +17

Significance of measurement of serum trough level and anti‐drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the <scp>DIAMOND</scp> trial

Hiroshi Nakase, Satoshi Motoya, Tomohiro Matsumoto et al. · Alimentary Pharmacology & Therapeutics · 2017 · 77 citations · Full text

, , +17

1–5 of 32